3-Bromo-4-cyanobenzoic acid(581213-69-6)
- Name: 3-Bromo-4-cyanobenzoic acid
- Synonyms:3-Bromo-4-cyanobenzoic acid
- Molecular Formula:C8H4BrNO2
- Molecular Weight:0
- CAS Registry Number:581213-69-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.581213-69-6 3-BROMO-4-CYANOBENZOIC ACID
Assay:鈮?5% Appearance:To be subject to the object Package:Customized Transportation:Air Application:pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou Dingyan Chem Co., Ltd [
China (Mainland)] CAS No.581213-69-6 3-bromo-4-cyanobenzoic Acid
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 579492-81-2/BAX INHIBITING PEPTIDE V5 (BIP-V5)
- 579515-38-1/2H-Benzimidazol-2-one,5-chloro-1,3-dihydro-1-methoxy-(9CI)
- 579523-65-2/Carbamic acid, [3-([1,1-biphenyl]-4-ylmethyl)-3,4-dihydro-4-oxo-2-propyl-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI)
- 581055-04-1/3,5-Pyridinedicarbonitrile,2-methoxy-4,6-dimethyl-(9CI)
- 579475-83-5/Benzonitrile, 3-(2-ethyl-6-methyl-4-pyridinyl)- (9CI)
- 579475-88-0/Pyridine, 5-bromo-2-ethyl-4-methyl- (9CI)
- 579479-13-3/1H-Imidazole,2-(1a,6-dihydrocycloprop[a]inden-6a(1H)-yl)-4,5-dihydro-,(+)-(9CI)
- 579486-61-6/1H-Imidazo[4,5-c]pyridine,4,6-dichloro-2-ethyl-(9CI)
- 583811-70-5/Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-(2-methylpropyl)- (9CI)
- 579476-50-9/3-(6-Chloropyrimidin-4-yl)benzoic acid
- 583811-64-7/Pyrazolo[3,4-b]azepine, 3-(1,1-dimethylethyl)-1-ethyl-1,4,5,6,7,8-hexahydro- (9CI)
- 583811-72-7/Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-(1-methylethyl)- (9CI)
- 579475-40-4/Benzonitrile, 3-(6-ethyl-3-pyridinyl)- (9CI)
- 581059-57-6/Benzonitrile, 2-[3-(2-benzofuranyl)-5,6,7,8-tetrahydropyrazolo[3,4-b]azepin-1(4H)-yl]- (9CI)
- 581094-59-9/Cyclopentanecarboxylic acid, 2,2,3-trimethyl-, (1S,3S)- (9CI)
- 581096-88-0/2(1H)-Pentalenone,hexahydro-3a,6a-dimethyl-4-(1-methylethenyl)-,(3aS,4S,6aS)-(9CI)
- 579457-51-5/Benzo[b]thiophene-2-carboxamide, 3-chloro-N-[(1,2-dihydro-6-methoxy-2-oxo-3-quinolinyl)methyl]-N-(2-furanylmethyl)- (9CI)
- 581092-38-8/1,4-Benzenediol, 3,5-dimethoxy-2-(2-propenyl)- (9CI)
- 581096-80-2/1(2H)-Pentalenone,hexahydro-3a,6a-dimethyl-,(3aR,6aR)-(9CI)
- 581213-69-6/3-Bromo-4-cyanobenzoic acid
- 581774-93-8/Benzoic acid, 3-[3-(2-benzofuranyl)-5,6,7,8-tetrahydropyrazolo[3,4-b]azepin-1(4H)-yl]- (9CI)
- 581781-20-6/Benzoic acid, 4-[[[2-(2-thienyl)-3-thiazolidinyl]thioxomethyl]amino]-, ethyl ester (9CI)
- 581782-45-8/L-Alanine, L-alanyl-, ion(1-) (9CI)
- 581793-29-5/Phenol, 2,3-difluoro-4-mercapto- (9CI)
- 581799-70-4/erythro-Pentonic acid, 4,5-dideoxy-2-O-methyl-2-C-phenyl-, ba-lactone (9CI)
- 581781-19-3/Benzoic acid, 4-[[[2-(4-bromophenyl)-3-thiazolidinyl]thioxomethyl]amino]-, ethyl ester (9CI)
- 583811-95-4/Pyrazolo[3,4-b]azepine, 3-butyl-1-ethyl-1,4,5,6,7,8-hexahydro- (9CI)
- 583823-98-7/2-Imidazolidinone 1-acetyl-, 4,4,5,5-tetramethyl- (7CI)
- 583840-03-3/SORAFENIB N-OXIDE
- 583861-17-0/Carbamic acid, (4,5-dihydro-5-methyl-4-oxo-2-oxazolyl)-, 1,1-dimethylethyl